We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.35%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
-$19M
(-8.7%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-14.57%
Top 10 Holdings %
Top 10 Hldgs %
5.74%
Holding
864
New
212
Increased
98
Reduced
280
Closed
274
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadridge
BR
|
+$1.44M |
| 2 |
RBC Bearings
RBC
|
+$1.16M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
+$1.14M |
| 4 |
Comcast
CMCSA
|
+$1.08M |
| 5 |
Caterpillar
CAT
|
+$984K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Technical Institute
UTI
|
+$921K |
| 2 |
Valaris
VAL
|
+$779K |
| 3 |
Reynolds Consumer Products
REYN
|
+$747K |
| 4 |
Trimble
TRMB
|
+$714K |
| 5 |
Novanta
NOVT
|
+$701K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.08% |
| 2 | Technology | 16.79% |
| 3 | Financials | 15.55% |
| 4 | Healthcare | 14.47% |
| 5 | Consumer Discretionary | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Viridian Therapeutics
VRDN
$2.13B
| $185K | 0.09% |
13,232
-510
| -4% | -$6.92K |
|
502
LXP Industrial Trust
LXP
$3.53B
| $185K | 0.09% |
+4,474
| New | +$184K |
|
503
Sinclair Inc
SBGI
$974M
| $184K | 0.09% |
13,344
-3,715
| -22% | -$52.8K |
|
504
Southern California Bancorp
BCAL
$676M
| $184K | 0.09% |
+11,690
| New | +$167K |
|
505
Select Water Solutions
WTTR
$2.51B
| $181K | 0.09% |
20,974
-20,587
| -50% | -$178K |
|
506
Suzano
SUZ
$10.2B
| $180K | 0.09% |
19,132
-10,652
| -36% | -$97.6K |
|
507
UWM Holdings
UWMC
$621M
| $179K | 0.09% |
+43,342
| New | +$191K |
|
|
ATXS
508
DELISTED
Astria Therapeutics
ATXS
| $179K | 0.09% |
+33,375
| New | +$162K |
|
509
Yext
YEXT
$501M
| $176K | 0.09% |
20,680
+10,130
| +96% | +$71K |
|
510
Custom Truck One Source
CTOS
$2.47B
| $175K | 0.09% |
35,357
+18,185
| +106% | +$78.4K |
|
511
Peabody Energy
BTU
$2.78B
| $174K | 0.09% |
12,929
-429
| -3% | -$5.66K |
|
512
STAAR Surgical
STAA
$1.16B
| $173K | 0.09% |
10,337
-398
| -4% | -$7.02K |
|
513
Kura Oncology
KURA
$922M
| $173K | 0.09% |
+30,025
| New | +$184K |
|
514
Ranger Energy Services
RNGR
$373M
| $173K | 0.09% |
14,494
-615
| -4% | -$7.38K |
|
515
Vaalco Energy
EGY
$594M
| $171K | 0.09% |
47,451
-38,951
| -45% | -$135K |
|
516
SunCoke Energy
SXC
$757M
| $170K | 0.09% |
19,827
-9,343
| -32% | -$81K |
|
517
Wipro
WIT
$18.5B
| $169K | 0.08% |
55,987
-2,156
| -4% | -$6.27K |
|
|
SHCO
518
DELISTED
Soho House & Co
SHCO
| $167K | 0.08% |
22,744
-43,962
| -66% | -$273K |
|
519
Manitowoc
MTW
$516M
| $166K | 0.08% |
+13,824
| New | +$136K |
|
|
VRE
520
DELISTED
Veris Residential
VRE
| $166K | 0.08% |
+11,141
| New | +$171K |
|
521
Payoneer
PAYO
$2.41B
| $166K | 0.08% |
+24,213
| New | +$164K |
|
522
Relay Therapeutics
RLAY
$4.02B
| $162K | 0.08% |
46,959
-24,527
| -34% | -$73K |
|
523
Cytek Biosciences
CTKB
$576M
| $162K | 0.08% |
+47,746
| New | +$159K |
|
524
Ranpak Holdings
PACK
$553M
| $162K | 0.08% |
45,334
+3,174
| +8% | +$11.8K |
|
525
Mativ Holdings
MATV
$448M
| $161K | 0.08% |
23,628
-53,531
| -69% | -$308K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q2 2025 Portfolio in Review
As of Q2 2025, EntryPoint Capital held 864 positions worth $200M, down 8.7% from $218M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
EntryPoint Capital withdrew a net $29.1M in Q2 2025, closing 274 positions and reducing 280 holdings. Its most notable exit was Universal Technical Institute, an estimated $921K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, EntryPoint Capital opened a new position in Broadridge worth $1.47M.
- EntryPoint Capital's largest Q2 2025 buy was Broadridge: 6,049 shares worth $1.47M.
- EntryPoint Capital added most to Rocket Pharmaceuticals in Q2 2025, an estimated $1.14M increase.
- EntryPoint Capital's biggest Q2 2025 reduction was Trimble, cutting an estimated $714K.
- EntryPoint Capital fully exited Universal Technical Institute in Q2 2025, selling an estimated $921K.
- EntryPoint Capital's ten largest holdings make up 5.7% of its $200M portfolio in Q2 2025.
- EntryPoint Capital opened 212 new positions and closed 274 in Q2 2025.
- EntryPoint Capital's portfolio value fell 8.7% quarter-over-quarter to $200M.
Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.